PAVmed Accounts Payable vs Total Current Liabilities Analysis

PAVMZ Stock  USD 0.01  0.00  0.00%   
PAVmed Series financial indicator trend analysis is much more than just breaking down PAVmed Series Z prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether PAVmed Series Z is a good investment. Please check the relationship between PAVmed Series Accounts Payable and its Total Current Liabilities accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Series Z. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Accounts Payable vs Total Current Liabilities

Accounts Payable vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of PAVmed Series Z Accounts Payable account and Total Current Liabilities. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between PAVmed Series' Accounts Payable and Total Current Liabilities is 0.57. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of PAVmed Series Z, assuming nothing else is changed. The correlation between historical values of PAVmed Series' Accounts Payable and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of PAVmed Series Z are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Accounts Payable i.e., PAVmed Series' Accounts Payable and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

0.57
Relationship DirectionPositive 
Relationship StrengthWeak

Accounts Payable

An accounting item on the balance sheet that represents PAVmed Series obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of PAVmed Series Z are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Total Current Liabilities

Total Current Liabilities is an item on PAVmed Series balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of PAVmed Series Z are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from PAVmed Series' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into PAVmed Series Z current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Series Z. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
At this time, PAVmed Series' Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 29.4 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 11.99 in 2024.

PAVmed Series fundamental ratios Correlations

0.280.460.3-0.58-0.660.990.99-0.590.75-0.10.790.451.00.790.780.660.62-0.55-0.540.780.550.520.70.75-0.66
0.280.36-0.270.07-0.440.240.24-0.010.160.030.430.370.25-0.16-0.030.530.17-0.120.10.190.560.560.150.46-0.11
0.460.36-0.690.44-0.970.370.37-0.540.86-0.030.91.00.40.210.570.910.74-0.61-0.47-0.080.950.960.810.91-0.73
0.3-0.27-0.69-0.940.510.410.410.12-0.280.0-0.32-0.70.380.470.1-0.47-0.280.160.020.7-0.61-0.64-0.26-0.380.18
-0.580.070.44-0.94-0.22-0.67-0.670.080.00.040.010.45-0.65-0.6-0.310.180.070.040.13-0.890.330.360.010.060.04
-0.66-0.44-0.970.51-0.22-0.58-0.580.63-0.920.06-0.98-0.97-0.6-0.35-0.66-0.96-0.770.640.55-0.16-0.96-0.96-0.86-0.980.76
0.990.240.370.41-0.67-0.581.0-0.550.7-0.090.730.361.00.80.770.580.55-0.52-0.520.850.450.420.650.69-0.63
0.990.240.370.41-0.67-0.581.0-0.550.7-0.090.730.361.00.80.770.580.55-0.52-0.520.850.450.420.650.69-0.63
-0.59-0.01-0.540.120.080.63-0.55-0.55-0.590.53-0.67-0.54-0.56-0.34-0.33-0.67-0.420.130.49-0.3-0.63-0.62-0.52-0.670.24
0.750.160.86-0.280.0-0.920.70.7-0.590.060.940.860.720.570.880.810.77-0.78-0.690.320.790.780.960.92-0.91
-0.10.03-0.030.00.040.06-0.09-0.090.530.06-0.07-0.03-0.090.110.25-0.130.11-0.23-0.45-0.07-0.15-0.140.29-0.1-0.28
0.790.430.9-0.320.01-0.980.730.73-0.670.94-0.070.90.750.480.740.940.76-0.66-0.590.350.920.910.890.99-0.79
0.450.371.0-0.70.45-0.970.360.36-0.540.86-0.030.90.390.20.560.910.73-0.61-0.47-0.090.950.960.80.91-0.72
1.00.250.40.38-0.65-0.61.01.0-0.560.72-0.090.750.390.790.780.60.57-0.53-0.530.830.480.450.670.71-0.64
0.79-0.160.210.47-0.6-0.350.80.8-0.340.570.110.480.20.790.80.370.53-0.52-0.570.540.210.170.570.39-0.61
0.78-0.030.570.1-0.31-0.660.770.77-0.330.880.250.740.560.780.80.540.64-0.86-0.680.470.460.440.860.68-0.92
0.660.530.91-0.470.18-0.960.580.58-0.670.81-0.130.940.910.60.370.540.74-0.49-0.490.140.980.970.770.94-0.63
0.620.170.74-0.280.07-0.770.550.55-0.420.770.110.760.730.570.530.640.74-0.42-0.50.140.70.680.770.75-0.81
-0.55-0.12-0.610.160.040.64-0.52-0.520.13-0.78-0.23-0.66-0.61-0.53-0.52-0.86-0.49-0.420.46-0.23-0.48-0.47-0.71-0.620.81
-0.540.1-0.470.020.130.55-0.52-0.520.49-0.69-0.45-0.59-0.47-0.53-0.57-0.68-0.49-0.50.46-0.29-0.41-0.4-0.84-0.540.56
0.780.19-0.080.7-0.89-0.160.850.85-0.30.32-0.070.35-0.090.830.540.470.140.14-0.23-0.290.030.010.290.33-0.28
0.550.560.95-0.610.33-0.960.450.45-0.630.79-0.150.920.950.480.210.460.980.7-0.48-0.410.031.00.730.93-0.6
0.520.560.96-0.640.36-0.960.420.42-0.620.78-0.140.910.960.450.170.440.970.68-0.47-0.40.011.00.720.93-0.59
0.70.150.81-0.260.01-0.860.650.65-0.520.960.290.890.80.670.570.860.770.77-0.71-0.840.290.730.720.86-0.88
0.750.460.91-0.380.06-0.980.690.69-0.670.92-0.10.990.910.710.390.680.940.75-0.62-0.540.330.930.930.86-0.76
-0.66-0.11-0.730.180.040.76-0.63-0.630.24-0.91-0.28-0.79-0.72-0.64-0.61-0.92-0.63-0.810.810.56-0.28-0.6-0.59-0.88-0.76
Click cells to compare fundamentals

PAVmed Series Account Relationship Matchups

PAVmed Series fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets7.2M19.8M87.0M54.0M33.1M23.6M
Other Current Liab1.4M(15.0M)4.3M3.7M6.6M7.0M
Total Current Liabilities11.9M20.0M7.6M41.2M54.2M56.9M
Total Stockholder Equity(3.8M)1.9M61.7M(9.7M)(53.8M)(51.1M)
Net Debt1.9M(2.3M)(77.3M)(3.1M)29.1M30.5M
Retained Earnings(53.7M)(88.3M)(138.9M)(228.2M)(294.4M)(279.7M)
Cash6.2M17.3M77.3M39.7M19.6M18.9M
Cash And Short Term Investments6.2M17.3M77.3M39.7M19.6M18.9M
Liabilities And Stockholders Equity7.2M19.8M87.0M54.0M33.1M23.6M
Capital Surpluse14.0M32.6M47.6M87.6M100.7M105.7M
Other Current Assets328.3B1.7M5.2M3.9M3.8M3.6M
Other Stockholder Equity47.6M87.6M198.1M215.9M237.6M249.5M
Total Liab11.9M20.3M7.6M43.0M57.1M60.0M
Total Current Assets6.5M18.9M82.6M43.9M24.5M20.8M
Common Stock40.5K64K86K95K9K8.6K
Accounts Payable2.4M3.0M3.3M2.7M1.8M2.1M
Non Current Assets Total692.9K837K4.3M10.1M8.6M9.1M
Common Stock Shares Outstanding2.0M3.2M5.2M5.9M7.2M7.6M
Non Current Liabilities Total10.5M300K4.3B1.8M3.0M2.8M
Short Long Term Debt Total7.9M8.1M15.0M36.6M48.7M51.2M
Net Invested Capital2.0M14.3M59.2M21.3M(12.6M)(12.0M)
Net Working Capital(5.3M)(1.0M)75.1M2.7M(29.7M)(28.2M)
Capital Stock2.3M2.6M2.5M2.8M3.0M2.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for PAVmed Stock Analysis

When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.